help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blethen, S. L.
Right arrow Articles by Chasalow, F. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blethen, S. L.
Right arrow Articles by Chasalow, F. I.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Growth Disorders

Journal of Clinical Endocrinology & Metabolism, Vol 57, 1031-1035, Copyright © 1983 by Endocrine Society


ARTICLES

Use of a two-site immunoradiometric assay for growth hormone (GH) in identifying children with GH-dependent growth failure

SL Blethen and FI Chasalow

Children with GH-dependent growth failure have normal GH responses to provocative stimuli, but, nonetheless, show increased growth rates when treated with replacement doses of human GH. We studied the GH secreted by 8 such children using a 2-site immunoradiometric assay for GH (IRMA- GH). To be detected in this assay, a GH molecule must be able to react simultaneously with two different monoclonal antibodies, each specific for a different region of the GH molecule. We compared the GH values observed in the IRMA to those obtained using classical RIA for GH (RIA- GH). The IRMA-GH to RIA-GH ratio was not affected by time of sample collection relative to peak GH serum levels in either normal individuals or children with GH-dependent growth failure. The ratios in serum samples from children with GH-dependent growth failure were significantly lower than those observed in normal individuals [0.35 +/- 0.005 vs. 0.48 +/- 0.02 (+/- SE); P less than 0.001]. All of the children with GH-dependent growth failure had IRMA-GH to RIA-GH ratios less than 0.4, while only 7 of 24 normal individuals had ratios this low (P less than 0.005). We suggest that a comparison of IRMA-GH with RIA-GH may supplement other clinical measurements and aid in identifying children with GH-dependent growth failure.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. P. Cemeroglu, A. L. Barkan, G. B. Kletter, I. Z. Beitins, and C. M. Foster
Changes in Serum Immunoreactive and Bioactive Growth Hormone Concentrations in Boys with Advancing Puberty and in Response to a 20-Hour Estradiol Infusion
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2166 - 2171.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Jansson, C. Boguszewski, S. Rosberg, L. Carlsson, and K. Albertsson-Wikland
Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein
Clin. Chem., June 1, 1997; 43(6): 950 - 956.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society